IL-8 –251A/T Polymorphism is Associated with Decreased Cancer Risk among Population-Based Studies: Evidence from a Meta-Analysis
Linbo Gao,Xue Pan,Jun Jia,Weibo Liang,Rao Li,Xue Hou,Yi Zhu,Shi-Liu Li,Meili Lv,Wei Deng,Tian-Yi Chen,Wei Yue,Lin Zhang
DOI: https://doi.org/10.1016/j.ejca.2010.03.011
IF: 10.002
2010-01-01
European Journal of Cancer
Abstract:Growing evidence suggests that interleukin-8 (IL-8) play pivotal roles in the pathogenesis of cancer through the modulation of tumour immune response or enhanced angiogenesis. A single nucleotide polymorphism, –251A/T, has been identified in the promoter region of the IL-8 gene and has been shown to influence its production. Results from previous studies on the association of –251A/T polymorphism with different cancer types remained contradictory. To assess the effect of –251A/T of IL-8 on cancer susceptibility, we conducted a meta-analysis, up to May 2009, of 14,876 cases with different cancer types and 18,465 controls from 45 published case–control studies. Summary odds ratios and corresponding 95% confidence intervals (CIs) for IL-8 polymorphism and cancer were estimated using fixed- and random-effects models when appropriate. The AA/AT genotypes were associated with a significantly increased risk of nasopharyngeal carcinoma when compared with TT genotype (OR = 1.48; 95% CI, 1.16–1.89). Moreover, significantly elevated risks were observed in 'other cancers', and also in African population when population is concerned. Interestingly, when stratified separately by population-based studies and hospital-based studies, significantly elevated risk was found among hospital-based studies (OR = 1.21, 95% CI, 1.07–1.37), whereas significantly decreased risk was found among population-based studies (OR = 0.90, 95% CI, 0.83–0.97). This meta-analysis shows that IL-8 –251A/T polymorphism may play a complex role in cancer development.